HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently

Kashi, Venkatesh Prasanna ; Jacob, Rajesh Abraham ; Paul, Siddhartha ; Nayak, Kaustuv ; Satish, Bhuthiah ; Swaminathan, Soumya ; Satish, Kadappa S. ; Ranga, Udaykumar (2009) HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently Vaccine, 27 (48). pp. 6739-6747. ISSN 0264-410X

Full text not available from this repository.

Official URL: http://www.sciencedirect.com/science/article/pii/S...

Related URL: http://dx.doi.org/10.1016/j.vaccine.2009.08.078

Abstract

Tat, an important regulatory protein of HIV-1, has been implicated in HIV-related pathogenesis. Immune responses to Tat, although underrepresented, confer protection against disease progression, in natural infection and experimental immunization, making Tat an attractive vaccine candidate. Information on immune responses to Tat from India which has the second largest HIV incidence has been lacking. Here we report a cross-sectional study evaluating the humoral response to Tat from a large number of samples from two southern states of India. 14% of the seropositive (63/447) and 4.6% of seronegative samples (7/150) harbored Tat-reactive antibodies. A significant number of the seropositive samples contained high levels of anti-Tat antibodies (31/447) which demonstrated class-switch to IgG1 and bound to Tat with high avidity. Cross-reactivity analysis showed that these antibodies interacted with Tat from different clades with variable degree withthe highest interaction with subtype-AE and the least with subtype-B Tat. Importantly, a B-cell epitope in the cysteine-rich domain was found to be the most immunodominant one and antibodies interacting with this epitope blocked extracellular Tat efficiently. To the best of our knowledge this is the first report on immune responses to Tat from Indian populations and the data presented here could significantly contribute to HIV Tat vaccine design.

Item Type:Article
Source:Copyright of this article belongs to Elsevier Science.
Keywords:HIV-1; Subtype C; Tat; Humoral Immune Response; Affinity Maturation; Isotype Switch; India; Natural Antibody; IgG; Tat Vaccine
ID Code:110322
Deposited On:01 Sep 2017 09:23
Last Modified:01 Sep 2017 09:23

Repository Staff Only: item control page